Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 10, 2004, Pages 1147-1154

  Smetana, Peter ^a,b   Pueyo, Esther ^a,c   Hnatkova, Katerina ^a   Batchvarov, Velislav ^a   Laguna, Pablo ^c   Malik, Marek ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Wilhelminenspital ^*  (Austria)

^c UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Antiarrhythmic agents; Heart rate; Repolarization; Sudden death

Indexed keywords

AMIODARONE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; RR INTERVAL; SUDDEN DEATH;

ADOLESCENT; ADULT; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FORECASTING; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SURVIVORS; TREATMENT OUTCOME;

EID: 7044249400     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.04076.x     Document Type: Article

References (41)

1. Rosenbaum MB, Chiale PA, Halpern MS, Nau GJ, Przybylski J, Levi RJ, Lazzari JO, Elizari MV: Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol 1976;38:934-944.
2. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P: Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 1997;349:667-674.
3. Cairns JA, Connolly SJ, Roberts R, Gent M: Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997;349:675-682.
4. Malik M, Camm AJ, Janse MJ, Julian DG, Frangin GA, Schwartz PJ: Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: A substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol 2000;35:1263-1275.
5. Torres V, Tepper D, Flowers D, Wynn J, Lam S, Keefe D, Miura DS, Somberg JC: QT prolongation and the antiarrhythmic efficacy of amiodarone. J Am Coll Cardiol 1986;7:142-147.
6. Horowitz LN, Greenspan AM, Spielman SR, Webb CR, Morganroth J, Rotmensch H, Sokoloff NM, Rae AP, Segal BL, Kay HR: Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. Am J Cardiol 1985;55:367-371.
7. Heger JJ, Prystowsky EN, Jackman WM, Naccarelli GV, Warfel KA, Rinkenberger RL, Zipes DP: Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med 1981;305:539-545.
8. Veltri EP, Griffith LS, Platia EV, Guarnieri T, Reid PR: The use of ambulatory monitoring in the prognostic evaluation of patients with sustained ventricular tachycardia treated with amiodarone. Circulation 1986;74:1054-1060.
9. Nasir N Jr, Swarna US, Boahene KA, Doyle TK, Pacifico A: Therapy of sustained ventricular arrhythmias with amiodarone: Prediction of efficacy with serial electrophysiologic studies. J Cardiovasc Pharmacol Ther 1996;1:123-132.
10. Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN: Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. Am J Cardiol 1988;61:1024-1030.
11. Yi G, Guo XH, Reardon M, Gallagher MM, Hnatkova K, Camm AJ, Malik M: Circadian variation of the QT interval in patients with sudden cardiac death after myocardial infarction. Am J Cardiol 1998;81:950-956.
12. Merri M, Moss AJ, Benhorin J, Locati EH, Alberti M, Badilini F: Relation between ventricular repolarization duration and cardiac cycle length during 24-hour Holler recordings. Findings in normal patients and patients with long QT syndrome. Circulation 1992;85:1816-1821.
13. Fei L, Statters DJ, Anderson MH, Katritsis D, Camm AJ: Is there anabnormal QT interval in sudden cardiac death survivors with a "normal" QTc? Am Heart J 1994;128:73-76.
14. Anderson KP, Walker R, Dustman T, Lux RL, Ershler PR, Kates RE, Une PM: Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo. Circulation 1989;79:948-958.
15. Huikuri HV, Yli-Mayry S: Frequency dependent effects of d-sotalol and amiodarone on the action potential duration of the human right ventricle. Pacing Clin Electrophysiol 1992;15:2103-2107.
16. Batchvarov VN, Ghuran A, Smetana P, Hnatkova K, Harris M, Dilaveris P, Camm AJ, Malik M: QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability. Am J Physiol Heart Circ Physiol 2002;282:H2356-H2363.
17. Boutitie F, Boissel JP, Connolly SJ, Camm AJ, Cairns JA, Julian DG, Gent M, Janse MJ, Dorian P, Frangin G: Amiodarone interaction with beta-blockers: Analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators. Circulation 1999;99:2268-2275.
18. Schwanz PJ, Wolf S: QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978;57:1074-1077.
19. Mason JW: Amiodarone. N Engl J Med 1987;316:455-466.
20. Haffajee CI, Love JC, Canada AT, Lesko LJ, Asdourian G, Alpert JS: Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation 1983;67:1347-1355.
21. Greenberg ML, Lerman BB, Shipe JR, Kaiser DL, DiMarco JP: Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity. J Am Coll Cardiol 1987;9:1148-1155.
22. Naccarelli GV, Fineberg NS, Zipes DP, Heger JJ, Duncan G, Prystowsky EN: Amiodarone: Risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study. J Am Coll Cardiol 1985;6:814-821.
23. Malik M: The imprecision in heart rate correction may lead to artificial observations of drug induced QT changes. Pacing Clin Electrophysiol 2002;25:209-216.
24. Debbas NM, du Cailar C, Bexton RS, Demaille JG, Camm AJ, Puech P: The QT interval: a predictor of the plasma and myocardial concentrations of amiodarone. Br Heart J 1984;51:316-320.
25. Haffajee CI, Love JC, Alpert JS, Asdourian GK, Sloan KC: Efficacy and safety of long-term amiodarone in treatment of cardiac arrhythmias: Dosage experience. Am Heart J 1983;106:935-943.
26. Sager PT, Uppal P, Follmer C, Antimisiaris M, Pruitt C, Singh BN: Frequency-dependent electrophysiologic effects of amiodarone in humans. Circulation 1993;88:1063-1071.
27. Fei L, Slade AK, Grace AA, Malik M, Camm AJ, McKenna WJ: Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: risk stratification and effect of low dose amiodarone. Pacing Clin Electrophysiol 1994;17:2222-2227.
28. Drouin E, Lande G, Charpentier F: Amiodarone reduces transmural heterogeneity of repolarization in the human heart. J Am Coll Cardiol 1998;32:1063-1067.
29. Sicouri S, Moro S, Litovsky S, Elizari MV, Antzelevitch C: Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart. J Cardiovasc Electrophysiol 1997;8:1269-1279.
30. Merot J, Charpentier F, Poirier JM, Coutris G, Weissenburger J: Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol. Cardiovasc Res 1999;44:303-314.
31. Sosunov EA, Artyukhovsky EP, Rosen MR: Chronic in vivo and in vitro effects of amiodarone on guinea pig hearts. J Pharmacol Exp Ther 1996;278:906-912.
32. Kodama I, Suzuki R, Kamiya K, Iwata H, Toyama J: Effects of long-term oral administration of amiodarone on the electromechanical performance of rabbit ventricular muscle. Br J Pharmacol 1992;107:502-509.
33. Browne KF, Prystowsky E, Heger JJ, Chilson DA, Zipes DP: Prolongation of the Q-T interval in man during sleep. Am J Cardiol 1983;52:55-59.
34. Drvota V, Haggblad J, Blange I, Magnusson Y, Sylven S: The effect of amiodarone on the beta-adrenergic receptor is due to a downregulation of receptor protein and not to a receptor-ligand interaction. Biochem Biophys Res Commun 1999;255:515-520.
35. Bosch RF, Li GR, Gaspo R, Nattel S: Electrophysiologic effects of chronic amiodarone therapy and hypothyroidism, alone and in combination, on guinea pig ventricular myocytes. J Pharmacol Exp Ther 1999;289:156-165.
36. Kamiya K, Nishiyama A, Yasui K, Hojo M, Sanguinetti MC, Kodama I: Short- and long-term effects of amiodarone on the two components of cardiac delayed rectifier K(+) current. Circulation 2001;103:1317-1324.
37. Groh WJ, Gibson KJ, Maylie JG: Comparison of the rate-dependent properties of the class III antiarrhythmic agents azimilide (NE-10064) and E-4031: Considerations on the mechanism of reverse rate-dependent action potential prolongation. J Cardiovasc Electrophysiol 1997;8:529-536.
38. Ks heterogeneity on action potential duration and its rate dependence: a simulation study. Circulation 1999;99:2466-2474.
39. Swan H, Viitasalo M, Piippo K, Laitinen P, Kontula K, Toivonen L: Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol 1999;34:823-829.
40. Jones DR, Pertunnen CD, Stuckman BE: Lipschitzian optimization without the Lipschitz constant. J Optimiz Theor Applic 1993;79:157-181.
41. Pueyo E, Smetana P, Laguna P, Malik M: Estimation of QT lag in response to RR changes. J Electrocardiol 2003;36(Suppl):187-190.